bims-tyki2d Biomed News
on Thymidine kinase 2 deficiency
Issue of 2026–11–01
three papers selected by
Zoya Panahloo, UCB



  1. Genes (Basel). 2026 Oct 08. pii: 1236. [Epub ahead of print]17(10):
      Rare genetic diseases (RGDs) affect more than 300-400 million people worldwide [...].
    DOI:  https://doi.org/10.3390/genes17101236
  2. Biochim Biophys Acta Mol Cell Res. 2026 Oct 24. pii: S0167-4889(26)00140-0. [Epub ahead of print] 120241
      Replication of the mitochondrial genome is essential to sustain cellular energy conversion, and defects in this process cause severe, progressive mitochondrial diseases that have long lacked curative treatment. This is now beginning to change: mechanistic insight into the replication machinery has started to translate into therapy, with the first disease-modifying treatment recently approved and others entering clinical evaluation. Here we review the molecular mechanisms of mitochondrial DNA replication, with emphasis on replication initiation, deletion formation, and replication completion, and discuss how insights into these processes are opening new therapeutic possibilities for treating mitochondrial disease.
    Keywords:  DNA replication; Deletion formation; Mitochondrial disease; POLG; Treatment
    DOI:  https://doi.org/10.1016/j.bbamcr.2026.120241